Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes: The international stem cell banking initiative

Stem Cell Reviews and Reports

Volumn 5, Issue 4, 2009, Pages 301-314

  Stacey, Glyn N ^a  

^a Blanche Lane   (United Kingdom)

Author keywords

Cell banking; Human embryonic stem cells; Microbiological testing; Pluripotency; Quality control; Standardisation

Indexed keywords

EID: 74549165987     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-009-9085-x     Document Type: Article

References (24)

1. Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., et al. (2005). Second ECVAM task force on Good Cell Culture practice. Guidance on good cell culture practice: a report of the second ECVAM task force on good cell culture practice. Alternatives to Laboratory Animals, 33, 261-287.
2. ISBER. (2007). Best practices for repositories I: collection, storage, and retrieval of human biological materials for research. Cell Preservation Technology, 3, 5-48.
3. OECD (2007) Best Practice Guidelines for Biological Resource Centres; OECD, Paris. http://www. oecd. org/document/50/0, 3343, en_2649_201185_1911986_1_1_ 1_1, 00. html.
4. OECD Advisory Document of the Working Group on Good Laboratory practice: the application of the principles of GLP to in vitro studies. OECD series on principles of Good laboratory practice and Compliance monitoring 2004; Number 14 (ENV/JM/MONO(2004)26), OECD, Paris. http://www. olis. oecd. org/olis/2004doc. nsf/linkTo/nT00008FEE/$FIlE/JT00174939. PdF.
5. International Conference on Harmonisation. ICH Topic Q 5 D Quality of Biotechnological Products: derivation and characterisation of cell substrates used for production of Biotechnological/Biological Products (CPMP/ICH/294/95), 1998; ICH Technical Coordination, European Medicines Evaluation Agency, London.
6. WHO (Expert Committee on Biological Standardization and Executive Board) requirements for the use of animal Cells as in vitro substrates for the production of biologicals (requirements for Biological substances no. 50). 1998; WHO technical report series no. 878; World Health Organization, Geneva.
7. Chatterjee, R. (2007). Cell biology: cases of mistaken identity. Science, 315, 928-931.
8. NIH (2007) Notice regarding authentication of cultured cell lines, NOTod-08-017, Nov 28, NiH. http://grants. nih. gov/grants/guide/notice-files/NOT-OD-08-017. html.
9. Editorial (2007). Nature Biotechnology, 1211-1212.
10. International Stem Cell Initiative: Adewumi, O., Aflatoonian, B., Ahrlundrichter, L, Amit, M., Andrews, P. W., Beighton, G., et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology, 25, 803-816.
11. Sikkema-Raddatz, B., Castedo, B., & Meerman, G. T. (1997). Probability tables for exclusion of mosaicism in prenatal diagnosis. Prenatal Diagnosis, 17, 115-118.
12. Hook, E. B. (1977). Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. American Journal of Human Genetics, 29, 94-97.
13. Association of Clinical Cytogenetics General Best Practice Guidelines. 2007; v10. 01, ACC Professional Standards Committee.
14. An International System for Human Cytogenetic Nomenclature (2009) In L. G. Shaffer, M. L. Slovak, L. J. Campbell (Eds.), Cytogenetic and Genome Research. Switzerland: Karger.
15. Bolske, G. (1988). Survey of mycoplasma infections in cell cultures and a comparison of detection methods. Zbl Bakt Nug, A269, 331-340.
16. Rottem, S., & Naot, Y. (1998). Subversion and exploitation of host cells by mycoplasma. Trends in Microbiology, 6, 436-440.
17. Timenetsky, J., Santos, L. M., Buzinhani, M., & Mettifogo, E. (2006). Detection of multiple mycoplasma infection in cell cultures by PCR. Brazilian Journal of Medical and Biological Research, 39, 907-914.
18. Eldering, J. A., Felton, C., Veilleux, C. A., & Potts, B. J. (2004). Development of a PCR method for mycoplasma testing of Chinese hamster ovary cell cultures used in the manufacture of recombinant therapeutic proteins. Biologicals, 32, 183-193.
19. van Kuppeveld, F. J. M., Johansson, K.-E., Galama, J. M. D., Kissing, J., Bolske, G., van der Logt, J. T. M., et al. (1994). Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Applied and Environmental Microbiology, 60, 149-152.
20. Sung, H., Kang, S. H., Bae, Y. J., Hong, J. T., Chung, Y. B., Lee, C.-K., et al. (2006). PCR-Based Detection of mycoplasma species. Journal of Microbiology, 44, 42-49.
21. Uphoff, C. C., & Drexler, H. G. (2005). Detection of mycoplasma contaminations. Methods in Molecular Biology, 290, 13-23.
22. Kong, H., Volokhov, D. V., George, J., Ikonomi, P., Chandler, D., Anderson, C., et al. (2007). Application of cell culture enrichment for improving the sensitivity of mycoplasma detection methods based on nucleic acid amplification technology (NAT). Applied Microbiology and Biotechnology, 77, 223-232.
23. Healy, L. E., Ludwig, T. E., & Choo, A. (2008). International banking: checks, deposits and withdrawals. Cell Stem Cell, 2(4), 305-306.
24. Crook, J. M., Hei, D., & Stacey, G. (2010). International Stem Cell Banking Initiative (ISCBI): Raising standards to bank on. In Vitro Cell Dev Biol-Animal, (in press).